Anna Norhammar
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Diabetes, Cardiovascular Risks, and Lipoproteins
-
- Cardiovascular Function and Risk Factors
- Heart Failure Treatment and Management
Papers in
-
- Diabetes Treatment and Management 43
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 14
- Diabetes Management and Research 12
- Diabetes, Cardiovascular Risks, and Lipoproteins 9
-
- Heart Failure Treatment and Management 14
- Cardiovascular Function and Risk Factors 12
- Co-authors
- Klas Malmberg (8 shared papers)Lars Rydén (7 shared papers)Lars Rydén (33 shared papers)Hans Wedel (6 shared papers)Åke Tenerz (7 shared papers)Johan Bodegård (38 shared papers)Marcus Thuresson (35 shared papers)Lars Rydén (17 shared papers)
- Journals
- European Heart Journal (14 papers)Diabetes and Vascular Disease Research (14 papers)Diabetes Obesity and Metabolism (12 papers)Cardiovascular Diabetology (11 papers)Diabetes Care (11 papers)
- Partner nations
- SwedenUnited KingdomNorway
In The Last Decade
Anna Norhammar
145 papers receiving 10.6k citations
Anna Norhammar's Hit Papers
Peers
Comparison fields: 5 of 130
- Endocrinology, Diabetes and Metabolism 5.9k
- Cardiology and Cardiovascular Medicine 2.8k
- Periodontics 296
- Nephrology 252
- Surgery 1.5k
Countries citing papers authored by Anna Norhammar
This map shows the geographic impact of Anna Norhammar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Norhammar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Norhammar more than expected).
Fields of papers citing papers by Anna Norhammar
This network shows the impact of papers produced by Anna Norhammar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Norhammar. The network helps show where Anna Norhammar may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Norhammar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 149 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD Hit paper breakdown → | 2019 | 3184 |
| 2 | Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study Hit paper breakdown → | 2002 | 863 |
| 3 | Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Infarction Hit paper breakdown → | 1999 | 678 |
| 4 | Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs Hit paper breakdown → | 2017 | 676 |
| 5 | Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs Hit paper breakdown → | 2018 | 373 |
| 6 | 2017 | 290 | |
| 7 | 2004 | 262 | |
| 8 | 1999 | 260 | |
| 9 | 2016 | 233 | |
| 10 | 2004 | 225 | |
| 11 | 2017 | 177 | |
| 12 | 2020 | 161 | |
| 13 | 2007 | 143 | |
| 14 | European Society of Cardiology: the 2023 Atlas of Cardiovascular Disease Statistics Hit paper breakdown → | 2024 | 140 |
| 15 | 2007 | 133 | |
| 16 | 2021 | 130 | |
| 17 | 2003 | 109 | |
| 18 | 2016 | 106 | |
| 19 | 2018 | 103 | |
| 20 | 2003 | 102 |
About Anna Norhammar
Anna Norhammar is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Periodontics, Epidemiology and Pulmonary and Respiratory Medicine, having authored 149 papers that have together received 11.1k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (43 papers), Heart Failure Treatment and Management (14 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (14 papers), Cardiovascular Function and Risk Factors (12 papers), Diabetes Management and Research (12 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers), Metabolism, Diabetes, and Cancer (9 papers) and Oral microbiology and periodontitis research (9 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (5.9k citations), Cardiology and Cardiovascular Medicine (2.8k citations), Periodontics (296 citations), Nephrology (252 citations) and Surgery (1.5k citations). Anna Norhammar has collaborated with scholars based in Sweden, United Kingdom and Norway. Frequent co-authors include Klas Malmberg, Lars Rydén, Lars Rydén, Hans Wedel, Åke Tenerz, Johan Bodegård, Marcus Thuresson, Lars Rydén, Anders Hamsten and Suad Efendić. Their work appears in journals such as European Heart Journal, Diabetes and Vascular Disease Research, Diabetes Obesity and Metabolism, Cardiovascular Diabetology and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.